Additionally, ERBB4 localization on hyper-proliferative endothelial structures in GBM samples and on endothelial cells derived from GBM patient samples further supports the inclusion of ERBB4 in targeted therapeutic strategies for GBM. Here, ERBB4 is linked to glioblastoma.